SyntekaBio, Inc. (KOSDAQ:226330)
South Korea · Delayed Price · Currency is KRW 4,035.00
-285.00 (-6.60%)
At close: Dec 10, 2025
SyntekaBio Revenue
SyntekaBio had revenue of 455.46M KRW in the quarter ending September 30, 2025, with 79,321.78% growth. This brings the company's revenue in the last twelve months to 1.78B, up 1,357.79% year-over-year. In the year 2024, SyntekaBio had annual revenue of 120.89M, down -2.04%.
Revenue (ttm)
1.78B
Revenue Growth
+1,357.79%
P/S Ratio
36.96
Revenue / Employee
34.30M
Employees
n/a
Market Cap
65.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | 609.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 315.56T |
| Hyundai Motor Company | 186.04T |
| Kia Corporation | 113.20T |
| SK hynix | 84.09T |
| LG Energy Solution | 23.98T |
| Hanwha Aerospace | 23.11T |
| Doosan Enerbility | 16.79T |
| HD Hyundai Heavy Industries | 16.39T |